Alumnus receives $5M to develop groundbreaking HIV/heroin vaccine
A Penn State alumnus who attended both Penn State Hazleton and University Park, has won an award that will pay him $5 million to research his proposal to develop a vaccine against HIV that also prevents heroin addiction.
Gary R. Matyas, a 1978 Penn State graduate in biophysics, captured the 2012 Avant-Garde Award for Medications Development from the National Institute on Drug Abuse with his plan to attack twin scourges.
"There is a strong correlation between heroin abuse and HIV infection, especially in developing countries," Matyas said of the Human Immunodeficiency Virus that causes AIDS. "The possibility of creating a combination heroin/HIV vaccine provides an important opportunity to address both a unique treatment for heroin abuse as well as continuing the quest to develop an effective preventive HIV vaccine."




















